Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer

ConclusionExcept for lymphedema and peripheral neuropathy, Black and White patients reported similar symptom severity during adjuvant chemotherapy. Dose reductions in Black patients were more common for non-anthracycline regimens. In this sample, there were minimal differences in patient-reported symptoms and other adverse outcomes in Black versus White patients.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research